Showing results (11-20 of 406) with videos related to
Sort By:
Pageof 41
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial designRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.Statistics in Medicine|August 21, 2020
Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trialsTobias Mütze, Susanna Salem, Norbert Benda, et al.Research Synthesis Methods|January 24, 2021
On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysisChristian Röver, Ralf Bender, Sofia Dias, et al.Biometrics|July 1, 2011
Discussion of the article by Trippa, Rosner, and Müller on Bayesian enrichment strategies for randomized discontinuation trialsHeinz Schmidli, Beat NeuenschwanderTherapeutic Advances in Neurological Disorders|May 6, 2022
Improving pediatric multiple sclerosis interventional phase III study design: a meta-analysisJennifer S Graves, Marius Thomas, Jun Li, et al.Statistics in Medicine|September 12, 2014
Optimal design of clinical trials with biologics using dose-time-response modelsMarkus R Lange, Heinz SchmidliStatistics in Medicine|June 11, 2015
Analysis of clinical trials with biologics using dose-time-response modelsMarkus R Lange, Heinz SchmidliStatistics in Medicine|November 21, 2017
Evidence synthesis from aggregate recurrent event data for clinical trial design and analysisBjörn Holzhauer, Craig Wang, Heinz SchmidliBiometrical Journal. Biometrische Zeitschrift|March 14, 2018
Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian-frequentist approachJohanna Mielke, Heinz Schmidli, Byron JonesStatistical Methods in Medical Research|January 6, 2012
The network meta-analytic-predictive approach to non-inferiority trialsHeinz Schmidli, Simon Wandel, Beat NeuenschwanderPageof 41